WASHINGTON, DC. Well over a thousand cases of rhabdomyolysis (an often fatal muscle disease) caused by the ingestion of statin drugs (atorvastatin [Lipitor],
simvastatin [Zocor], lovastatin [Mevacor], pravastatin [Pravachol]) have been reported. Now the FDA has issued a warning not to take more than 20 mg/day
of simvastatin if also taking amiodarone since doing so will markedly increase the risk of rhabdomyolysis. The warning also applies to the combination of
simvastatin and ezetimibe (Vytorin) and the combination of simvastatin and extended-release niacin (Simcor). The FDA press release states that:
Editor�s comment: If a combination of amiodarone and 20 mg/day or more of simvastatin is dangerous enough to require a warning,
how dangerous is amiodarone plus 10 mg/day? Who knows? The FDA does not seem to.
What is perhaps more disturbing is that the FDA has no data regarding the effect of amiodarone dosage on
rhabdomyolysis incidence when combined with simvastatin. Could simvastatin combined with a loading
dose of amiodarone (800 � 1600 mg/day) be vastly more dangerous than the combination of simvastatin and an
amiodarone maintenance dose of 200 � 400 mg/day? Nobody knows, so afibbers on or contemplating amiodarone
should be very careful about also taking statin drugs, particularly simvastatin.
|